Thibault J. Harmand

1.4k total citations · 1 hit paper
18 papers, 877 citations indexed

About

Thibault J. Harmand is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Thibault J. Harmand has authored 18 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in Thibault J. Harmand's work include Chemical Synthesis and Analysis (5 papers), Influenza Virus Research Studies (4 papers) and Peptidase Inhibition and Analysis (4 papers). Thibault J. Harmand is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Influenza Virus Research Studies (4 papers) and Peptidase Inhibition and Analysis (4 papers). Thibault J. Harmand collaborates with scholars based in United States, Japan and Switzerland. Thibault J. Harmand's co-authors include Hidde L. Ploegh, Novalia Pishesha, Jeffrey W. Bode, Fabian B. H. Rehm, Vijaya R. Pattabiraman, Ashraful Islam, Ross W. Cheloha, Thomas Durek, David J. Craik and Thomas Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Thibault J. Harmand

17 papers receiving 867 citations

Hit Papers

A guide to antigen processing and presentation 2022 2026 2023 2024 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thibault J. Harmand United States 11 536 300 222 181 93 18 877
Weijie Dong China 17 613 1.1× 216 0.7× 59 0.3× 85 0.5× 97 1.0× 32 784
Chuanfei Yu China 18 613 1.1× 175 0.6× 172 0.8× 318 1.8× 37 0.4× 67 971
Murli Krishna United States 11 633 1.2× 295 1.0× 111 0.5× 215 1.2× 27 0.3× 14 942
Martin Schlapschy Germany 17 651 1.2× 225 0.8× 178 0.8× 364 2.0× 25 0.3× 31 1.0k
Yariv Mazor United States 16 860 1.6× 236 0.8× 215 1.0× 669 3.7× 55 0.6× 24 1.3k
Noboru Uchiyama Japan 15 973 1.8× 410 1.4× 166 0.7× 327 1.8× 287 3.1× 35 1.3k
Mayumi Ishihara United States 18 728 1.4× 185 0.6× 66 0.3× 105 0.6× 219 2.4× 35 1.1k
Przemysław Golik Poland 10 278 0.5× 230 0.8× 374 1.7× 111 0.6× 41 0.4× 15 669
Kathrin Stavenhagen Netherlands 21 993 1.9× 358 1.2× 66 0.3× 296 1.6× 256 2.8× 30 1.2k
Zhaowen Luo United States 14 462 0.9× 331 1.1× 329 1.5× 94 0.5× 34 0.4× 15 816

Countries citing papers authored by Thibault J. Harmand

Since Specialization
Citations

This map shows the geographic impact of Thibault J. Harmand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thibault J. Harmand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thibault J. Harmand more than expected).

Fields of papers citing papers by Thibault J. Harmand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thibault J. Harmand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thibault J. Harmand. The network helps show where Thibault J. Harmand may publish in the future.

Co-authorship network of co-authors of Thibault J. Harmand

This figure shows the co-authorship network connecting the top 25 collaborators of Thibault J. Harmand. A scholar is included among the top collaborators of Thibault J. Harmand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thibault J. Harmand. Thibault J. Harmand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Harmand, Thibault J., et al.. (2025). A multivalent nanobody–drug conjugate to prevent and treat influenza virus infections. Proceedings of the National Academy of Sciences. 122(45). e2409565122–e2409565122.
2.
Koopman, Gerrit, Petra Mooij, Thibault J. Harmand, et al.. (2024). Imaging the immune sequelae of infection with SARS‐CoV‐2 in nonhuman primates by using two nanobody PET‐tracers. Journal of Medical Virology. 96(10). e29956–e29956. 1 indexed citations
3.
Pishesha, Novalia, Thibault J. Harmand, & Hidde L. Ploegh. (2022). A guide to antigen processing and presentation. Nature reviews. Immunology. 22(12). 751–764. 412 indexed citations breakdown →
4.
Pishesha, Novalia, Thibault J. Harmand, Xin Liu, et al.. (2022). Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms. Proceedings of the National Academy of Sciences. 119(43). e2211065119–e2211065119. 9 indexed citations
5.
Harmand, Thibault J., Ashraful Islam, Novalia Pishesha, & Hidde L. Ploegh. (2021). Nanobodies as in vivo , non-invasive, imaging agents. RSC Chemical Biology. 2(3). 685–701. 41 indexed citations
6.
Islam, Ashraful, Novalia Pishesha, Thibault J. Harmand, et al.. (2021). Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4+ T Cells. The Journal of Immunology. 207(5). 1468–1477. 12 indexed citations
7.
Pishesha, Novalia, Thibault J. Harmand, Leif S. Ludwig, et al.. (2021). Induction of antigen-specific tolerance by nanobody–antigen adducts that target class-II major histocompatibility complexes. Nature Biomedical Engineering. 5(11). 1389–1401. 34 indexed citations
8.
Harmand, Thibault J., et al.. (2021). Asparaginyl Ligase-Catalyzed One-Step Cell Surface Modification of Red Blood Cells. ACS Chemical Biology. 16(7). 1201–1207. 26 indexed citations
9.
Cheloha, Ross W., et al.. (2020). Exploring cellular biochemistry with nanobodies. Journal of Biological Chemistry. 295(45). 15307–15327. 63 indexed citations
10.
Rehm, Fabian B. H., Thibault J. Harmand, Kuok Yap, et al.. (2019). Site-Specific Sequential Protein Labeling Catalyzed by a Single Recombinant Ligase. Journal of the American Chemical Society. 141(43). 17388–17393. 77 indexed citations
11.
Harmand, Thibault J., Djenet Bousbaine, Alix I Chan, et al.. (2018). One-Pot Dual Labeling of IgG 1 and Preparation of C-to-C Fusion Proteins Through a Combination of Sortase A and Butelase 1. Bioconjugate Chemistry. 29(10). 3245–3249. 77 indexed citations
12.
Harmand, Thibault J.. (2018). Enantioselective Synthesis of (S)-Ethyl 2-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino)-4-oxobutanoate. Organic Syntheses. 95. 142–156. 1 indexed citations
13.
Harmand, Thibault J., et al.. (2017). Improved synthesis of (S)-N-Boc-5-oxaproline for protein synthesis with the α-ketoacid-hydroxylamine (KAHA) ligation. Bioorganic & Medicinal Chemistry. 25(18). 4996–5001. 7 indexed citations
14.
Harmand, Thibault J., Vijaya R. Pattabiraman, & Jeffrey W. Bode. (2017). Chemical Synthesis of the Highly Hydrophobic Antiviral Membrane‐Associated Protein IFITM3 and Modified Variants. Angewandte Chemie International Edition. 56(41). 12639–12643. 35 indexed citations
15.
Harmand, Thibault J., Vijaya R. Pattabiraman, & Jeffrey W. Bode. (2017). Chemical Synthesis of the Highly Hydrophobic Antiviral Membrane‐Associated Protein IFITM3 and Modified Variants. Angewandte Chemie. 129(41). 12813–12817. 10 indexed citations
16.
Harmand, Thibault J., et al.. (2016). Protein chemical synthesis by α-ketoacid–hydroxylamine ligation. Nature Protocols. 11(6). 1130–1147. 40 indexed citations
17.
Harmand, Thibault J., Sameer S. Kulkarni, & Jeffrey W. Bode. (2015). Optimized synthesis of a cyanosulfurylide linker for Fmoc-SPPS of C-terminal peptide α-ketoacids. Tetrahedron Letters. 56(23). 3477–3480. 5 indexed citations
18.
Harmand, Thibault J., et al.. (2014). New chemistries for chemoselective peptide ligations and the total synthesis of proteins. Current Opinion in Chemical Biology. 22. 115–121. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026